Dersleri yüzünden oldukça stresli bir ruh haline sikiş hikayeleri bürünüp özel matematik dersinden önce rahatlayabilmek için amatör pornolar kendisini yatak odasına kapatan genç adam telefonundan porno resimleri açtığı porno filmini keyifle seyir ederek yatağını mobil porno okşar ruh dinlendirici olduğunu iddia ettikleri özel sex resim bir masaj salonunda çalışan genç masör hem sağlık hem de huzur sikiş için gelip masaj yaptıracak olan kadını gördüğünde porn nutku tutulur tüm gün boyu seksi lezbiyenleri sikiş dikizleyerek onları en savunmasız anlarında fotoğraflayan azılı erkek lavaboya geçerek fotoğraflara bakıp koca yarağını keyifle okşamaya başlar
Reach Us +44-3308187254


Anticholinesterase and Antioxidant Potentials of a Medicinal Plant Abroma augusta: Implications for the Alternative Treatment Therapy of Cognitive Deficits in Alzheimers disease
ISSN: 2167-065X
Clinical Pharmacology & Biopharmaceutics
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business

Anticholinesterase and Antioxidant Potentials of a Medicinal Plant Abroma augusta: Implications for the Alternative Treatment Therapy of Cognitive Deficits in Alzheimers disease

Mst. Marium Begum1, Kushal Biswas2, Arjyabrata Sarker3, Tamanna Binte Huq4, Abeer Sarwar4, Md. Belal Hossain5, Hasan Tarek5, Md. Noor-A-Alam5and Asma Rahman6*
1Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Dhaka, Dhaka-1000, Bangladesh
2Department of Pharmacy, University of Rajshahi, Rajshahi-6205, Bangladesh
3Department of Pharmacy, Jahangirnagar University, Savar, Dhaka-1342, Bangladesh
4Department of Pharmaceutical Sciences, North South University, Dhaka-1229, Bangladesh
5Department of Pharmacy, Dhaka International University, Dhaka-1213, Bangladesh
6Centre for Advanced Research in Sciences (CARS), University of Dhaka, Dhaka-1000, Bangladesh
Corresponding Author : Asma Rahman
Centre for Advanced Research in Sciences (CARS)
University of Dhaka, Dhaka-1000, Bangladesh
Tel: +8801718617915
Received: August 07, 2015; Accepted: October 23, 2015; Published: October 28, 2015
Citation: Begum MM, Biswas K, Sarker A, Huq TB, Sarwar A, et al. (2015) Anticholinesterase and Antioxidant Potentials of a Medicinal Plant Abroma augusta: Implications for the Alternative Treatment Therapy of Cognitive Deficits in Alzheimer’s disease. Clin Pharmacol Biopharm 4:148. doi:10.4172/2167- 065X.1000148
Copyright: © 2015 Begum MM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Clinical Pharmacology & Biopharmaceutics


Oxidative stress and low level of neurotransmitter (especially acetylcholine) are main characteristics of Alzheimer’s disease (AD), a progressive neurodegenerative disease. Prolonging the function of acetylcholine by inhibiting acetylcholinesterase or butyrylcholinesterase enzyme and reducing oxidative stress with antioxidants are most effective treatment therapy of AD. Abroma augusta is a well-known medicine plant with a variety of medicinal uses. In this study we examine cholinesterase inhibitory activity as well as antioxidant activity of dried fruit extract including crude methyl extract and its sub fractions (Chloroform fraction, Petroleum ether fraction, Ethyl acetate fraction and aqueous fraction) of A. augusta. Both cholinergic inhibitory activity and antioxidant activity of various fractions suggested that, ethyl acetate fraction are most prominent among all fractions and can be used in symptomatic treatment of AD.

AD is a progressively developing neurodegenerative cognitive disorder of the brain, primarily found in the elder person with symptoms of memory loss, cognitive and behavioral abnormalities [1-5]. Alzheimer’s Association estimated that one of eight persons in America, after age 65, suffer from AD. According to this estimation the number of AD patients will be 16 million by 2050 [6].
The pathology of AD is complex and multifaceted. Several pathogenic conditions are believed to contribute to the progression of disease. Oxidative stress, cholinergic deficit and senile plaque formation are some major sign of AD [7-9]. Among several causes that play vital role in oxidative stress are beta amyloid, reactive oxygen species and reactive nitrogen species. All of these cause major destruction of brain area like cortex and hippocampus in the early stages of AD [10,11]. Acetylcholinesterase enzyme (AChE) is a prominent marker of AD. Formation of relatively AChE cause more breakdown of ACh in the brain and ultimately cause decrease of ACh in the nervous system [12,13]. Similarly Butyrylcholinestyerase (BChE) enzyme act synergistically with AChE to hydrolyze both ACh and Butyrylcholine in the nerve endings [14,15]. Both AChE and BChE are involved in the breakdown of neurotransmitter. So by inhibiting these enzyme results increase concentration of ACh in the CNS leads to improve cognitive functions [16-19]. β-amyloid associated free radicals can initiate lipid peroxidation, protein oxidation, ROS formation, intracellular and mitochondrial Ca2+ accumulation and eventually lead to death of neurons [20-24]. Therefore, inhibition of Cholinesterase enzyme and prevent oxidative stress devised as a suitable strategy for providing symptomatic treatment to AD as well as other forms of dementia and myasthenia gravis [25,26].
The synthetic drugs approved for AD from FDA such as Tacrine, Rivastigmine and Donepezil are associated with a lot of adverse effects like gastrointestinal disturbance, liver associated problems and other nervous system. Beside these expensiveness further adds limitations of these drugs [27-29] All these limitations prompts an urgent need to look for new lead compound from different sources including plant based natural products.
Abroma augusta (Family: Sterculiaceae, Bengali name: Ulatkambal, English name: Devil’s cotton, DC) a species of Abroma, with a dark red flower with an characteristics appearance [30]. Geographically it is widely distributed in Asia (especially India, Bangladesh and Sri Lanka). It is one of the most widely used medicinal plants in the treatment of various ailments. The root parts of the plants were used as a uterine tonic and several urine disorders. Powdered root plants acts as an abortification and fertility agent. Leaves are useful in treating uterine disorder, diabetes, rheumatic pains of the joint infections, headache with sinusitis. Leaves and stems are documented as gonorrhea treating agent [31-37].
Primarily the plant contains alkaloids. The root bark of the plant contain alkaloids (abromine), sterol (friedelin, abromasterol, taraxesteryl acetate, taraxerol β sitosterol) etc [38]. Although A. augusta has important medicinal value no studies have yet examined for its anti-alzheimer’s activities. This study discusses the investigation of dried fruit extract of A. augusta in antioxidant, acetylcholinesterase and butyrylcholinesterase inhibitory point of view relevant to the treatment of Alzheimer’s Disease.
Method and Materials
Almost all chemicals were used in this study are analytical grade. Acetylthiocholine iodide, Butyryllthiocholine iodide, Donepezil, Galantamine, Folin–Ciocalteu reagent, 2-deoxy-D-ribose, thiobarbituric acid, (+)-catechin, 5, 5’dithio-bis-(2-nitro) benzoic acid, Gallic Acid were brought from Sigma-Aldrich (Tokyo, Japan). Aluminium chloride, Ammonium molybdate, Ascorbic acid (AA), DPPH, Tris-HCl and Triton X-100 were obtained from Wako Pure Chemical Company Ltd. (Osaka, Japan). Solvents are used in this experiment are also analytical grade.
Plants materials
Fruits of A. augusta are collected from Rajshahi, Bangladesh in January and February 2014. All fruits are authenticated by an expert taxonomist from Botany Department of Rajshahi University. Beside this a voucher specimen were submitted to the herbarium of University of Rajshahi, Bangladesh.
Preparation of the sample
After collection ripe fruits were dried into shadow. The dried fruit were cut into small pieces and ground into fine powder using a dry grinder. The grinded sample were sieved to get uniform particle size and kept it into air tight container.
Powdered fruit (500 g) were placed into an amber coated bottle and soaked into 1500 mL of methanol. The contents were sealed into bottle for 7 days with occasionally stirred and shaken in every 30 minutes. After 7 days the whole mixture were filtered by Whitman No. 1 filter papers and filtrated were finally concentrated with rotary evaporator under reduced pressure below 50°C. About 16.298 gm of crude methanolic extract (CME) were found.
An aliquot of (12 gm) of concentrated CME were further fractionated by petroleum ether, Chloroform, Ethyl Acetate and pure double distilled water to get petroleum ether extract (PEF), Chloroform extract fraction (CEF), Ethyl Acetate fraction (EAF) and pure Aqueous fraction (AQF) respectively. The process were done on the basis of polarity [39,40]. Non-polar solvents were used first then less polar and finally polar solvents are added to the extract. The extraction methods are done by modified kupchan method.
Analysis of antioxidant properties
1,2-diphenyl-2-picrylhydrazyl radical (DPPH) scavenging activity [41]: 0.1 mL of various concentrations of sample was mixed with 0.4 mL of 0.3 mM DPPH reagent prepared in methanol. Mixture were shaken and kept into dark at room temperature for 30 min. absorbance of the reaction mixture was taken at 517 nm. DPPH free radical scavenging activity was calculated by the following formula:
% of scavenging =image
Determination of hydroxyl radical scavenging activity [42]: Hydroxyl radical scavenging activity of the samples was determined by using 2-deoxy-d-ribonucleic acid. To generate hydroxyl radical Ferric- Ascorbate-EDTA-H2O2 system were used. The reaction contained 2-deoxy-d-ribonucleic acid (2.8 nM), KH2PO4-KOH buffer (20 nM, pH 7.4). FeCl3 (100 μM), H2O2 (1.0 mM), Ascorbic Acid and various concentration of samples or standards (+) Catechin was used as a reference standard. Reaction mixture incubated for 1hour at 37°C after incubation 0.5 mL reaction mixture added to 1 mL 2.8% Thiobarbituric acid and 1 mL 1% ice cool Tricholoroacetic acid. The whole mixture incubated at 100°C for 30 minutes to develop colors. After cooling absorbances were taken at 532 nm against an appropriate blank solution. Following formula of calculating scavenging activity:
% of scavenging = image
Determination of nitric oxide radical scavenging activity [43,44]: Nitric Oxide radical scavenging activity was determined by using sodium nitroprusside 5mM, prepared in phosphate buffer pH 7.4. 1 mL of various concentrations of fractions, sodium nitroprusside 0.3 mL was added. The test tubes were incubated for 5 hour at 25ºC. Afterward 0.5 mL of Griess reagent was added to the test tubes. Absorbance was taken at 546 nm.
Determination of reducing power [45,46]: Reducing power of the sample were determined by Oyaizu method [42]. Plant extract/ Standard (1 mL) were mixed with 2.5 mL Potassium buffer Potassium ferricyanide and incubated at 50°C for 20 min. 2.5 mL of CCl3COOH (10%) solution added to it. Then reaction mixture centrifuged at 3300 RPM for 10 min. After that 2.5 mL supernatant of the reaction mixture, 2.5 mL distilled water and 0.5 mL FeCl3 (1%) solution were taken into a test tube. Absorbance was taken at 700 nm. Ascorbic acid was used as reference standard.
Determination of lipid peroxidation inhibition assay [47-49]: Lipid peroxidation inhibition assay were determined by Liu method with slight modification. About 150 g adult long Evan rats brain were dissected and homogenized with a homogenizer in ice-cold phosphate buffer (50 mM, pH 7.4) to produce a 1/10 homogenate (as lipid source). The homogenate was centrifuged for 15 min in 10000 rpm at 4°C. The final supernatant was used as liposome for an in vitro lipid peroxidation assay. Supernatant treated with hydrogen peroxide (10 μM) and different concentrations of plant extract where hydrogen peroxide induced lipid peroxidation. Lipid peroxides treated with thiobarbituric acid to form a pink color and absorbance taken at 532 nm. The difference between the control and plant extract treated sample was the measured decrease in thiobarbituric acid reacting substances formation, reflecting reduced hydroxyl radical-induced lipid peroxidation.
Determination of AChE inhibitory activity [50-52]:
Ellman’s colorimetric method was applied to run AChE inhibitory assay and acetylthiocholine iodide used as a substrate. For the enzyme source, the bovine brains were homogenized in a homogenizer with ten volumes of a homogenation buffer (10 Mm Tris-HCl, pH 7.2), which contained 1 M NaCl, 50 mM MgCl2 and1%Triton X-100 and centrifuged at 10000 rpm for 30 min. The resulting supernatant was treated with super saturated ammonium sulphate solution and floating precipitation was collected. Solution of this precipitation was used as an enzyme source. Temperatures were maintained (4°C) throughout the excretion procedure. A bicinchoninic acid kit was used to determine protein concentration and bovine serum albumin used as a protein standard. AChE hydrolysis rate were monitored spectrophotometrically. Each extract or standard (500 μL) was mixed with an enzyme solution (500 μL) and incubated at 37°C for 30 min. Absorbance at 405 nm was read immediately after adding Ellman’s reaction mixture (3.5 mL 0.5 mM acetylthiocholine, 1 mM 5, 5´-dithiobis (2-nitro benzoic acid)) in a 50 mM sodium phosphate buffer (pH 8.0) to the above reaction mixture. To verify the reaction reading were repeated for 10 min at 2 min intervals. The blank reaction was measured by substituting buffer saline for the enzyme (Figure 1). Donepezil was used as a positive control. The percentage inhibition of AChE activity was calculated using the following formula:
% of Inhibition of AChE = image
Determination of BuChE inhibitory activity [50-52]: Modified Ellman’s colorimetric methods were used to perform BuChE inhibitory assay, where butyrylthiocholine iodide used as a substrate. Human blood plasma used as enzyme source. BuChE hydrolysis rate were monitored spectrophotometrically. Each extract or standard (500 μL) was mixed with an enzyme solution (500 μL) and incubated at 37°C for 30 min. Absorbance at 405 nm was read immediately after adding Ellman’s reaction mixture (3.5 mL 0.5 mM butyrylthiocholine, 1 mM 5, 5´-dithio-bis (2-nitro benzoic acid)) in a 50 mM sodium phosphate buffer (pH 8.0) to the above reaction mixture. To verify the reaction reading were repeated for 10 min at 2 min intervals. The blank reaction was measured by substituting saline for the enzyme. Galantamine was used as a reference standard (Figure 2). The percentage inhibition of AChE activity was calculated using the following formula:
% of Inhibition of BuChE = image
Statistical analysis
All analyses tests were done three times to get most reliable results. Experimental data were presented as mean ± SD. For graphical analysis Microsoft Excel 2010 were used. For statistical evaluation free R-software version 2.15.1 were utilized. By using the t-test Significant differences (P-value<0.05) between the means were determined.
AChE inhibitory activity
The colorimetric method of Ellman, [50] which is based on determining the amount of Thiocholine releases when acetylcholine is hydrolyzed by acetylcholinesterase enzyme. The thiocholine released in the reaction mixture were determined by using DTNB. As reduction of DTNB in Hippocampus and cortex is most remarkable hallmark of AD, therefore, elevation of Ach in the synaptic cleft by inhibiting AChE (enzyme that causes breakdown of Ach) are widely accepted therapeutic strategy of AD. The inhibitory activity of AChE by CME other subfractions of A. augusta were determined by Ellman’s method. The inhibitory activities of various fractions are given in Table1 (Figure 3).
From the Table 1 it is found that AChE inhibitory activity of A. augusta is concentrated depended. With increase of concentration activity increases and after a certain period it saturates. Among all the fractions EAF is found most active which inhibits 23.83 ± 2.12% AChE at concentration 100 μg/mL, whereas CME, ClF, AQF and PEF inhibits 19.43 ± 1.429%, 9.18 ± 2.622%, 8.33 ± 1.871% and 7.23 ± 2.028% respectively at the same concentration. Donepezil used as a reference standard which inhibits 97.47 ± 2.375% at the same concentration.
BChE inhibitory activity [50-52]
BChE has been found active in the progression of AD as it is also reduces the availability of Ach by hydrolyzing it. BChE have synergistic effect with ACHE to hydrolyze ACH. Inhibiting this enzyme also found effective in treating AD patients. BChE inhibitory activity of different fraction of A. augusta are given in Table 2.
The result truly indicates that EAF was the most active fraction in inhibiting BuCH. At the concentration of 100μg/mL EAF inhibits 20.25 ± 1.522% of BuCH whereas CME, PET, ClF and AQF inhibits 12.17 ± 1.821%, 3.52 ± 0.938%, 6.59 ± 1.829% and 7.52 ± 1.128% of BCH respectively. For reference Galantamine was used and at the concentration of 100 μg/mL it inhibits about 95.84 ± 2. 575%.
DPPH radical scavenging activity
Free radical causes huge damage to the brain and neurons. Scavenging of these radicals is an important strategy to treat AD. For free radical scavenging activity, DPPH radical scavenging model is well accepted. DPPH is a stable colored free radical which loses its color when free radicals are scavenged. The percentage of free radical scavenging activity was relatively high in EAF compare to others. IC50 value of EAF is 12.6 μg/mL whereas CME, AQF, ClF and PET have 21.9 μg/mL, 29.8 μg/mL, 70.2 μg/mL and 58.6 μg/mL respectively. Reference standard Catechin possesses IC50 of 3.8 μg/mL (Figure 4).
Nitric oxide (NO) scavenging activity
NO free radical plays an important role in the pathogenesis of inflammation. This inflammatory process can lead to oxidative stress. By inhibiting these free radicals nerve cells can be safe from free radical related inflammations, which is beneficial for AD patients. Fractions of A. augusta shows NO free radical scavenging activities. Among all the fractions EAF shows highest scavenging activity compared to others with the IC50 of 55.63 μg/mL. CME, PEF, ClF and AQ have IC50 67.19, 82.92, 132.17 and 72.17 μg/mL respectively. Standard Ascorbic acid has IC50 of 47.29 μg/mL (Figure 5).
Hydroxyl radical scavenging activity
Hydroxyl radicals are most reactive oxygen species that causes lipid oxidation and fat oxidation and other biological damages. These may cause oxidative stress and ultimate cell death by apoptosis. For detecting hydroxyl scavenging activity Fe3+-Ascorbate-EDTA_ H2O2 system were applied to all extracts by evaluating the degree of deoxyribose degeneration.
All of the extract gives hydroxyl radical scavenging activity. Among all EAF found most prominent with the IC50 of 18.75 μg/mL compared to CME, PET, ClF and AQF with IC50 of 25.93, 45.92, 56.24 and 35.31 μg/mL respectively (Figure 6). Catechin was used as reference standard, which exhibits IC50 9.5 μg/mL.
Lipid Peroxidation Inhibition activity
In AD patients ROS production by Aβ protein causes various pathophysiological effects including lipid peroxidation and cellular degeneration. Lipid peroxidation causes the formation of low molecular weights lipids by oxidation of poly unsaturated fatty acids. In lipid peroxidation inhibition test oxidized polyunsaturated fatty acid reacts with two molecules of thiobarbituric acid and produce pink chromogen.
Extracts exhibits lipid peroxidation inhibition activity in various degree. Among all the fractionsEAF found most prominent. IC50 of EA fraction was 37.31 μg/mL while CME, PEF, ClF and AQF had IC50 of 47.22, 91.33, 112.34 and 66.71 μg/mL (Figure 7) Catechin was used as reference standard, which exhibits IC50 16.54 μg/mL.
Reduction of Birth rate and increased life expectancy resulted increase of average age which also rings age related problem in forward [53]. AD one of the most common age related problem having no cure at all. But several factors can be effective to suppressive severity of this disease. A number of factors have been identified, oxidative stress, and cholinergic dysfunctions are the major contributor factor of AD [54,55]. Earlier studies have been reported that, there some plant derivative product that have direct use on this disease. So, as a source of new medicine plants are always good participants.
A. augusta was used from the very past for various disease condition. It has been renowned for its anti-diabetic, anti-rheumatic and anti-gonorrheal use [56]. in this study we evaluate its antialzheimer’s activity. Our finding suggested that A. augusta also possess anti-oxidative activity but al ACHE and BuCHE inhibitory activity. It is well recognized that inhibition of ACHE is one of the most effective strategy. In this study we found that inhibition of ACHE by CME and its subtraction were occurred by dose dependent manner and the highest activity was found in EAF (23.87%) compared to other fractions. Under similar condition Donepezil an anti-AD drug with potential ACHE inhibitory activity, inhibit at the enzyme almost 97%.Our results show moderate inhibitory activity of A. augusta. It resembles that Donepezil have much more activity than this fraction. But EAF is just a fraction not a single isolated compound.
BuCHE another crucial enzyme involved in AD [57]. It hydrolyzes both BuCHE and ACHE and also influence the activity of ACHE in breakdown of ACHE. So, breakdown of BuCHE is also an effective way in the treatment of AD. Our study revealed the A. augusta have anti-BuCHE activity. Several fractions show various type of ability to hydrolyze BuCHE. Among the entire fraction EAF was most prominent in case of BuCHE inhibition. EAF found most active fraction with inhibition capability of 12.17%. It is found active compared to others which indicates A. augusta possess both ACHE and BuCHE inhibitory activity.
It is found that antioxidant have a promising effect in the treatment of AD by effecting A-β protein formation and oxidative stress [58-61]. Different fraction of A. augusta gives different potentialantioxidant activities. Antioxidants provide their activity mainly scavenging the free radicals that formed into the cells. In our in-vitro study we found that, these fractions isolated from the plant part shows various degrees of antioxidant activities. In DPPH free radical scavenging activity EAF found most active than others with IC50 of 12.6 μg/mL. The order of antioxidant activity was like this CME>AQF>PEF>CIF (Table 3).
For hydroxyl and Nitric Oxide free radical scavenging activity, EAF founds bet. Studies indicate that, ROS which formed during oxidative stress induce cellular and molecular abnormalities in AD. HO and NO are the main ROS that cause damage to neuron. Among all extracts EAF found most active with IC50 of the other fractions [62-66].
When lipids are attacked by ROS lipid peroxidation occurs which cause formation of carbon radical that react with O2 resulting the formation of peroxyl radical and caused lipid peroxides generation [67-70]. Brain cells contain high percentages of fat. Thus, lipid peroxidation in AD patient is more dangerous than others. A. augusta found active in lipid peroxidation inhibition.The inhibition rate varies extract to extract but EAF found most active among all.
The ACHE and BuCHE inhibitory property with antioxidant activity of A. augesta were supported by the presence of endogenous alkaloids, tannin, steroids, polyphenol and flavonoids in it, as these are involved in absorbing or neutralizing free radicals.
It was formed to reduce oxidative stress and inhibition of ACHE, BuCHE. Our overall study indicates that A. augusta can contribute to inhibition of both ACHE and BuCHE which also possess antioxidant activity.
The result suggested that EAF extended from A. augusta effectively inhibits both ACHE and BuCHE. This fraction also possesses antioxidant stress. As a result, EAF has found a potential source of cholinesterase inhibitor and antioxidant which can be an effective and safe alternative treatment for AD.



Tables and Figures at a glance

Table icon Table icon Table icon
Table 1 Table 2 Table 3


Figures at a glance

Figure Figure Figure Figure
Figure 1 Figure 2 Figure 3 Figure 4


Figure Figure Figure
Figure 5 Figure 6 Figure 7
Post your comment

Share This Article

Article Usage

  • Total views: 13905
  • [From(publication date):
    November-2015 - Sep 23, 2023]
  • Breakdown by view type
  • HTML page views : 9631
  • PDF downloads : 4274